Skip to content
10-K

Annual Report

Pyxis Oncology, Inc. PYXS

0001193125-26-118532

← back to feed
Filed
Mar 23, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 20, 2026 62.83M sh
Shares Diluted FY 2025 · Dec 31, 2025 62.14M sh
Shares Diluted FY 2025 · Dec 31, 2024 58.45M sh
Capex FY 2025 · Dec 31, 2025 $9K
Capex FY 2025 · Dec 31, 2024 $237K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$63.5M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$57.67M
Cash And Equivalents FY 2025 · Dec 31, 2025 $15.42M
Cash And Equivalents FY 2025 · Dec 31, 2024 $19.47M
Stockholders Equity FY 2025 · Dec 31, 2025 $53.41M
Stockholders Equity FY 2025 · Dec 31, 2024 $120.75M
Stockholders Equity FY 2025 · Dec 31, 2023 $125.7M
Current Liabilities FY 2025 · Dec 31, 2025 $21.13M
Current Liabilities FY 2025 · Dec 31, 2024 $17.68M
Total Liabilities FY 2025 · Dec 31, 2025 $38.11M
Total Liabilities FY 2025 · Dec 31, 2024 $36.43M
Current Assets FY 2025 · Dec 31, 2025 $72.11M
Current Assets FY 2025 · Dec 31, 2024 $132.44M
Total Assets FY 2025 · Dec 31, 2025 $91.52M
Total Assets FY 2025 · Dec 31, 2024 $157.18M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.28
Eps Diluted FY 2025 · Dec 31, 2024 −$1.32
Eps Basic FY 2025 · Dec 31, 2025 −$1.28
Eps Basic FY 2025 · Dec 31, 2024 −$1.32
Sga Expense FY 2025 · Dec 31, 2025 $22.19M
Sga Expense FY 2025 · Dec 31, 2024 $25.42M
Rd Expense FY 2025 · Dec 31, 2025 $73.7M
Rd Expense FY 2025 · Dec 31, 2024 $58.75M
Net Income FY 2025 · Dec 31, 2025 −$79.62M
Net Income FY 2025 · Dec 31, 2024 −$77.33M
Operating Income FY 2025 · Dec 31, 2025 −$84.42M
Operating Income FY 2025 · Dec 31, 2024 −$89.46M
Cost Of Revenue FY 2025 · Dec 31, 2025 $2.39M
Cost Of Revenue FY 2025 · Dec 31, 2024 $475K
Revenue FY 2025 · Dec 31, 2025 $13.86M
Revenue FY 2025 · Dec 31, 2024 $16.15M